Catalyst Wire Dossier Catalyst Wire Dossier

DTaP vaccine (diphtheria-tetanus-recombinant acellular pertussis)

Diphtheria, Tetanus, and Acellular Pertussis (DTaP) vaccine · BioNet-Asia Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DTaP vaccine (diphtheria-tetanus-recombinant acellular pertussis), covering 2025-10-08 to 2025-10-08. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity of a Combined Diphtheria-Tetanus-recombinant Acellular Pertussis (DTaP) Vaccine in Healthy Toddlers [Phase 2, Phase 3]

See pricing